BioTime Company

BioTime is leading the next revolution in medicine – regenerative medicine. Regenerative medicine utilizes advances in stem cell biology, biomaterials, lab-generated cells and tissues, and biologics to engineer and provide healthy cells, tissues and organs to patients with chronic degenerative diseases. This revolution in medical science changes the focus from treating the symptoms of chronic and degenerative diseases to providing actual cures.

Headquarters: Boston, Massachusetts, United States
Employee Number: 1-10
Founded Date: 1990-01-01
Investment Stage: N/A
Technology: Regenerative medicine - cell therapy
Estimated Revenue: $1M to $10M
Investor Type: N/A
Number Of Exists: 1
Industry: BioTech
Funding Status: IPO